Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55Gag

被引:95
|
作者
Sandefur, S
Smith, RM
Varthakavi, V
Spearman, P
机构
[1] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA
关键词
D O I
10.1128/JVI.74.16.7238-7249.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus (HIV) type 1 particles assemble at the plasma membrane of cells in a manner similar to that of the type C oncoretroviruses. The Pr55(Gag) molecule directs the assembly process and is sufficient for particle assembly in the absence of all other viral gene products. The I domain is an assembly domain that has been previously localized to the nucleocapsid (NC) region of Gag. In this study we utilized a series of Gag-green fluorescent protein (GFP) fusion proteins to precisely identify sequences that constitute the N-terminal I domain of pr55(Gap). The minimal sequence required for the I domain was localized to the extreme N terminus of NC. Two basic residues (arginine 380 and arginine 384) within the initial seven residues of NC were found to be critical for the function of the N-terminal I domain. The presence of positive charge alone in these two positions, however, was not sufficient to mediate the formation of dense Gag particles. The I domain was required for the formation of detergent-resistant complexes of Gag protein, and confocal microscopy demonstrated that the I domain was also required for the formation of punctate foci of Gag proteins at the plasma membrane. Electron microscopic analysis of cells expressing Gag-GFP fusion constructs with an intact I domain revealed numerous retrovirus-like particles (RVLPs) budding from the plasma membrane, while I domain-deficient constructs failed to generate visible RVLPs. These results provide evidence that Gag-Gag interactions mediated by the I domain play a central role in the assembly of HIV particles.
引用
收藏
页码:7238 / 7249
页数:12
相关论文
共 50 条
  • [11] Substitution of the myristoylation signal of human immunodeficiency virus type 1 Pr55Gag with the phospholipase C-δ1 pleckstrin homology domain results in infectious pseudovirion production
    Urano, Emiko
    Aoki, Toru
    Futahashi, Yuko
    Murakami, Tsutomu
    Morikawa, Yuko
    Yamamoto, Naoki
    Komano, Jun
    JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 3144 - 3149
  • [12] Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag
    Harila, K
    Prior, I
    Sjöberg, M
    Salminen, A
    Hinkula, J
    Suomalainen, M
    JOURNAL OF VIROLOGY, 2006, 80 (08) : 3765 - 3772
  • [13] Identification of the glycoprotein 41TM cytoplasmic tail domains of human immunodeficiency virus type 1 that interact with Pr55Gag particles
    Hourioux, C
    Brand, D
    Sizaret, PY
    Lemiale, F
    Lebigot, S
    Barin, F
    Roingeard, P
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (12) : 1141 - 1147
  • [14] The host protein staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization
    Chatel-Chaix, Laurent
    Abrahamyan, Levon
    Frechina, Celine
    Mouland, Andrew J.
    DesGroseillers, Luc
    JOURNAL OF VIROLOGY, 2007, 81 (12) : 6216 - 6230
  • [15] Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55gag and p17MA
    Hermida-Matsumoto, L
    Resh, MD
    JOURNAL OF VIROLOGY, 1999, 73 (03) : 1902 - 1908
  • [16] Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55Gag:: Functional linkage between translation and RNA packaging
    Poon, DTK
    Chertova, EN
    Ott, DE
    VIROLOGY, 2002, 293 (02) : 368 - 378
  • [17] Comparison of human immunodeficiency virus type 1 Pr55Gag and Pr160Gag-Pol processing intermediates that accumulate in primary and transformed cells treated with peptidic and nonpeptidic protease inhibitors
    Speck, RR
    Flexner, C
    Tian, CJ
    Fu, XF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) : 1397 - 1403
  • [18] CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PR55(GAG) MEMBRANE ASSOCIATION IN A CELL-FREE SYSTEM - REQUIREMENT FOR A C-TERMINAL DOMAIN
    PLATT, EJ
    HAFFAR, OK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) : 4594 - 4598
  • [19] Human immunodeficiency virus type 1 Vif protein binds to the Pr55(Gag) precursor
    Bouyac, M
    Courcoul, M
    Bertola, G
    Baudat, Y
    Gabuzda, D
    Blanc, D
    Chazal, N
    Boulanger, P
    Sire, J
    Vigne, R
    Spire, B
    JOURNAL OF VIROLOGY, 1997, 71 (12) : 9358 - 9365
  • [20] Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly
    Morikawa, Y
    Hockley, DJ
    Nermut, MV
    Jones, IM
    JOURNAL OF VIROLOGY, 2000, 74 (01) : 16 - 23